NeutraSal (Supersaturated Calcium Phosphate Rinse)

The clinical need to treat oral mucositis

Prevalence and impact

Oral mucositis is a frequent complication of chemotherapy and/or radiation therapy1,2

  • Oral mucositis can affect a majority of patients undergoing radiation and/or chemotherapy treatment for head and neck cancer
  • Over 40% of cancer patients undergoing conventional chemotherapy develop oral mucositis

Oral mucositis can lead to significant health complications, including2:

  • The need for analgesics or opioid analgesics for pain relief
  • The possibility of missed cancer therapy doses, dose interruptions, dose limitations, and treatment failure
  • Increase in the risk of significant infection

1. Peterson DE. New strategies for management of oral mucositis in cancer patients. J Support Oncol. 2006;4(1):009-013. 2. Sonis ST, Oster G, Fuchs H, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 2001;19(8):22012205.

*Terms and Conditions: This offer is only valid for patients with commercial insurance where NeutraSal Supersaturated Calcium Phosphate Rinse is a covered medication. This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other governmental programs, including, but not limited to, Medicare (including Medicare Advantage and Part A, B, and D plans), Medicaid, TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan, or any other federal or state health care programs. By using this program, the patient agrees not to seek reimbursement for all or any part of the benefit received through this offer and is responsible for making any required reports of use of this offer to any insurer or other third party who pays any part of the prescription filled. This offer is good only in the United States of America (including the District of Columbia, Puerto Rico and the U.S. Virgin Islands). This offer is not valid where otherwise prohibited, taxed, or otherwise restricted and not valid for any person that is 65 years of age or older without commercial insurance. Patients must be 18 years of age or older to redeem this offer for themselves or a minor. This offer cannot be redeemed at government-subsidized clinics. This offer is valid for one (1) initial prescription fill of NeutraSal and up to ten (10) prescription refills. The maximum benefit available is $150 per box. Participating patients are responsible for all costs and expenses after the maximum benefit is reached. If the patient receives coverage through a health savings account (HSA) or similar arrangement, it is the patient’s responsibility to know how claims are processed and understand that amounts paid by the third party for their NeutraSal prescription may be deducted from their benefits limit automatically. This offer is not valid with other offers. The coupon has no cash value or cash back. This offer is not health insurance. This offer expires on December 31, 2016. Valeant Pharmaceuticals and OraPharma reserve the right to rescind, revoke, terminate, or amend this offer at any time, without notice.